AMBISOME

AMPHOTERICIN B · Astellas Pharma US, Inc.

Drug timelines are a Plus or Pro feature.

44 regulatory and trial events tracked for AMBISOME, covering 2008-06-16 to 2026-04-23. Get the full timeline:

Most recent: Clinical Trial Update: Liposomal Amphotericin B and Flucytosine Antifungal Strategy for Talaromycosis (LAmB-FAST) [Phase 3]